Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 67 | 2023 | 876 | 7.400 |
Why?
|
Erythrocytes | 35 | 2024 | 641 | 5.440 |
Why?
|
Proteome | 30 | 2023 | 353 | 5.250 |
Why?
|
Blood Preservation | 20 | 2024 | 311 | 4.380 |
Why?
|
Blood Proteins | 14 | 2020 | 248 | 4.210 |
Why?
|
Extracellular Matrix Proteins | 12 | 2023 | 133 | 3.600 |
Why?
|
Shock, Hemorrhagic | 21 | 2023 | 206 | 3.350 |
Why?
|
Fibrinolysis | 14 | 2022 | 159 | 3.180 |
Why?
|
Extracellular Matrix | 24 | 2023 | 446 | 3.150 |
Why?
|
Metabolomics | 28 | 2024 | 550 | 3.070 |
Why?
|
Mass Spectrometry | 35 | 2023 | 681 | 2.900 |
Why?
|
Blood Coagulation Disorders | 11 | 2023 | 208 | 2.890 |
Why?
|
Lymph | 8 | 2018 | 40 | 2.880 |
Why?
|
Metabolome | 19 | 2021 | 296 | 2.790 |
Why?
|
Wounds and Injuries | 17 | 2022 | 772 | 2.660 |
Why?
|
Hemolysis | 10 | 2024 | 174 | 2.070 |
Why?
|
Peptide Hydrolases | 3 | 2023 | 108 | 1.830 |
Why?
|
Plasma | 12 | 2023 | 224 | 1.790 |
Why?
|
Chromatography, Liquid | 16 | 2020 | 355 | 1.730 |
Why?
|
Tandem Mass Spectrometry | 15 | 2018 | 421 | 1.500 |
Why?
|
Mesentery | 5 | 2014 | 56 | 1.500 |
Why?
|
Animals | 116 | 2023 | 33399 | 1.300 |
Why?
|
Erythrocyte Transfusion | 10 | 2022 | 210 | 1.260 |
Why?
|
Glycolysis | 8 | 2021 | 224 | 1.220 |
Why?
|
Blood Platelets | 7 | 2022 | 369 | 1.180 |
Why?
|
Isotope Labeling | 6 | 2018 | 76 | 1.140 |
Why?
|
Multiple Trauma | 2 | 2023 | 97 | 1.090 |
Why?
|
Arginine | 6 | 2023 | 249 | 1.070 |
Why?
|
Thrombosis | 7 | 2023 | 309 | 1.020 |
Why?
|
Tissue Plasminogen Activator | 9 | 2023 | 230 | 1.010 |
Why?
|
Plateletpheresis | 2 | 2015 | 28 | 1.010 |
Why?
|
Energy Metabolism | 10 | 2021 | 767 | 1.000 |
Why?
|
Collagen | 8 | 2022 | 433 | 0.990 |
Why?
|
Humans | 159 | 2024 | 119032 | 0.980 |
Why?
|
Oxidative Stress | 16 | 2022 | 1179 | 0.970 |
Why?
|
Thrombelastography | 12 | 2023 | 192 | 0.960 |
Why?
|
Brain Injuries, Traumatic | 3 | 2023 | 318 | 0.950 |
Why?
|
Protein Domains | 4 | 2022 | 212 | 0.940 |
Why?
|
Hemorrhage | 9 | 2023 | 623 | 0.910 |
Why?
|
Furin | 1 | 2022 | 13 | 0.900 |
Why?
|
Glycocalyx | 3 | 2022 | 23 | 0.890 |
Why?
|
Lymph Nodes | 3 | 2018 | 455 | 0.880 |
Why?
|
Breast Neoplasms | 11 | 2021 | 1965 | 0.860 |
Why?
|
Oxidation-Reduction | 15 | 2022 | 940 | 0.800 |
Why?
|
Peptides | 7 | 2023 | 879 | 0.790 |
Why?
|
Mammary Glands, Animal | 6 | 2021 | 124 | 0.780 |
Why?
|
Hemoglobins | 5 | 2023 | 326 | 0.780 |
Why?
|
Fibrin | 3 | 2023 | 60 | 0.780 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 348 | 0.780 |
Why?
|
Coronavirus Infections | 3 | 2020 | 339 | 0.770 |
Why?
|
Resuscitation | 11 | 2023 | 253 | 0.770 |
Why?
|
Sex Characteristics | 4 | 2022 | 671 | 0.770 |
Why?
|
Proteins | 6 | 2022 | 938 | 0.770 |
Why?
|
Blood Banks | 3 | 2021 | 43 | 0.750 |
Why?
|
Mice | 46 | 2023 | 15528 | 0.750 |
Why?
|
Rats, Sprague-Dawley | 21 | 2022 | 2478 | 0.740 |
Why?
|
Pentose Phosphate Pathway | 5 | 2021 | 44 | 0.740 |
Why?
|
Saccharomyces cerevisiae Proteins | 8 | 2022 | 348 | 0.740 |
Why?
|
Plasminogen Activator Inhibitor 1 | 4 | 2022 | 82 | 0.740 |
Why?
|
Male | 71 | 2023 | 57818 | 0.740 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 2017 | 332 | 0.740 |
Why?
|
Amino Acids | 6 | 2020 | 465 | 0.730 |
Why?
|
Chromatography, High Pressure Liquid | 11 | 2019 | 490 | 0.730 |
Why?
|
Biomarkers | 20 | 2022 | 3590 | 0.720 |
Why?
|
Peptide Mapping | 3 | 2019 | 63 | 0.720 |
Why?
|
Interleukin-6 | 2 | 2020 | 692 | 0.710 |
Why?
|
Factor XIIIa | 1 | 2019 | 5 | 0.700 |
Why?
|
Rats | 28 | 2023 | 5394 | 0.690 |
Why?
|
Female | 69 | 2023 | 61588 | 0.680 |
Why?
|
Saccharomyces cerevisiae | 9 | 2022 | 495 | 0.680 |
Why?
|
Actins | 3 | 2020 | 404 | 0.680 |
Why?
|
Sciuridae | 2 | 2019 | 145 | 0.670 |
Why?
|
Complement System Proteins | 2 | 2021 | 294 | 0.650 |
Why?
|
Sodium Chloride | 3 | 2015 | 144 | 0.640 |
Why?
|
Hydroxylamine | 1 | 2017 | 6 | 0.630 |
Why?
|
Postpartum Period | 4 | 2020 | 271 | 0.630 |
Why?
|
Carbon | 2 | 2017 | 170 | 0.620 |
Why?
|
Tissue Scaffolds | 3 | 2019 | 184 | 0.620 |
Why?
|
Pancreatic Neoplasms | 6 | 2021 | 734 | 0.620 |
Why?
|
Tumor Microenvironment | 9 | 2021 | 454 | 0.610 |
Why?
|
Hypoxia | 8 | 2023 | 963 | 0.610 |
Why?
|
Glucose | 5 | 2018 | 954 | 0.600 |
Why?
|
Blood Coagulation | 6 | 2023 | 219 | 0.600 |
Why?
|
Neutrophils | 7 | 2022 | 1233 | 0.590 |
Why?
|
High-Throughput Screening Assays | 5 | 2021 | 122 | 0.580 |
Why?
|
Hibernation | 2 | 2019 | 77 | 0.580 |
Why?
|
Myocardium | 6 | 2022 | 970 | 0.580 |
Why?
|
Pandemics | 4 | 2023 | 1355 | 0.580 |
Why?
|
Citric Acid | 1 | 2016 | 34 | 0.580 |
Why?
|
Brain Death | 1 | 2016 | 29 | 0.560 |
Why?
|
Endothelial Cells | 5 | 2023 | 732 | 0.560 |
Why?
|
Citrates | 2 | 2017 | 48 | 0.550 |
Why?
|
Lung | 9 | 2022 | 3666 | 0.550 |
Why?
|
Diethylhexyl Phthalate | 1 | 2015 | 9 | 0.550 |
Why?
|
Protein Processing, Post-Translational | 9 | 2019 | 408 | 0.540 |
Why?
|
Succinic Acid | 5 | 2020 | 46 | 0.540 |
Why?
|
Tissue Engineering | 3 | 2019 | 363 | 0.540 |
Why?
|
Metabolic Flux Analysis | 1 | 2015 | 7 | 0.540 |
Why?
|
Hydroxylysine | 1 | 2015 | 4 | 0.530 |
Why?
|
Extinction, Biological | 1 | 2015 | 29 | 0.520 |
Why?
|
Phosphates | 2 | 2020 | 168 | 0.520 |
Why?
|
Altitude Sickness | 5 | 2017 | 163 | 0.520 |
Why?
|
Blood Donors | 5 | 2024 | 109 | 0.510 |
Why?
|
Adult | 41 | 2022 | 31525 | 0.510 |
Why?
|
Organ Preservation Solutions | 1 | 2014 | 44 | 0.500 |
Why?
|
Lymphatic Vessels | 1 | 2015 | 54 | 0.500 |
Why?
|
Fibrinogen | 6 | 2023 | 161 | 0.480 |
Why?
|
Injury Severity Score | 5 | 2020 | 528 | 0.480 |
Why?
|
Reperfusion Injury | 5 | 2023 | 276 | 0.470 |
Why?
|
Swine | 12 | 2023 | 731 | 0.470 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 246 | 0.460 |
Why?
|
Chondrogenesis | 3 | 2020 | 80 | 0.460 |
Why?
|
Amino Acid Sequence | 9 | 2019 | 2073 | 0.450 |
Why?
|
Crotalus | 2 | 2023 | 18 | 0.450 |
Why?
|
Hydrogels | 6 | 2023 | 584 | 0.450 |
Why?
|
Adenine | 1 | 2014 | 223 | 0.450 |
Why?
|
Crotalid Venoms | 2 | 2023 | 31 | 0.440 |
Why?
|
Time Factors | 14 | 2018 | 6414 | 0.440 |
Why?
|
Spliceosomes | 4 | 2019 | 38 | 0.440 |
Why?
|
Adenosine | 4 | 2018 | 211 | 0.440 |
Why?
|
Balloon Occlusion | 2 | 2023 | 26 | 0.430 |
Why?
|
Stromal Cells | 3 | 2020 | 102 | 0.430 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2021 | 210 | 0.430 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2012 | 72 | 0.430 |
Why?
|
Hemostatics | 2 | 2023 | 50 | 0.430 |
Why?
|
Taste Buds | 1 | 2015 | 211 | 0.430 |
Why?
|
Fibrinolysin | 3 | 2022 | 17 | 0.430 |
Why?
|
Superoxides | 2 | 2022 | 221 | 0.420 |
Why?
|
Ibuprofen | 1 | 2012 | 76 | 0.420 |
Why?
|
Blast Injuries | 2 | 2022 | 42 | 0.420 |
Why?
|
Solutions | 3 | 2019 | 156 | 0.420 |
Why?
|
Extracellular Vesicles | 3 | 2021 | 76 | 0.410 |
Why?
|
RNA-Binding Proteins | 3 | 2023 | 371 | 0.410 |
Why?
|
Cell Line, Tumor | 16 | 2023 | 2851 | 0.410 |
Why?
|
Cells, Cultured | 15 | 2020 | 4081 | 0.400 |
Why?
|
Ribonucleoprotein, U4-U6 Small Nuclear | 3 | 2017 | 11 | 0.400 |
Why?
|
Gelsolin | 3 | 2020 | 9 | 0.400 |
Why?
|
Lysine | 4 | 2023 | 248 | 0.400 |
Why?
|
Molecular Sequence Data | 10 | 2015 | 2873 | 0.390 |
Why?
|
Middle Aged | 25 | 2021 | 27627 | 0.380 |
Why?
|
Gamma Rays | 2 | 2021 | 52 | 0.380 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 827 | 0.370 |
Why?
|
Erythrocyte Membrane | 3 | 2021 | 52 | 0.370 |
Why?
|
Glutamine | 4 | 2019 | 88 | 0.370 |
Why?
|
Fibroblasts | 6 | 2021 | 843 | 0.360 |
Why?
|
Adaptation, Physiological | 4 | 2017 | 502 | 0.360 |
Why?
|
Membrane Lipids | 3 | 2020 | 88 | 0.350 |
Why?
|
Membrane Proteins | 5 | 2023 | 1056 | 0.350 |
Why?
|
Workflow | 2 | 2023 | 148 | 0.350 |
Why?
|
Disease Models, Animal | 16 | 2023 | 3730 | 0.350 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2022 | 139 | 0.350 |
Why?
|
Histones | 6 | 2022 | 552 | 0.340 |
Why?
|
Inflammation | 8 | 2023 | 2571 | 0.340 |
Why?
|
Ultrasonics | 1 | 2009 | 53 | 0.340 |
Why?
|
Cellular Reprogramming | 2 | 2021 | 85 | 0.330 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2019 | 79 | 0.330 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2021 | 176 | 0.330 |
Why?
|
Muscle, Skeletal | 7 | 2023 | 1523 | 0.330 |
Why?
|
Endovascular Procedures | 2 | 2023 | 275 | 0.330 |
Why?
|
RNA Splicing | 3 | 2019 | 243 | 0.330 |
Why?
|
Brain Neoplasms | 3 | 2022 | 1023 | 0.320 |
Why?
|
Tranexamic Acid | 3 | 2019 | 37 | 0.320 |
Why?
|
Lactic Acid | 4 | 2018 | 282 | 0.320 |
Why?
|
Models, Molecular | 9 | 2021 | 1435 | 0.320 |
Why?
|
RNA | 3 | 2023 | 833 | 0.320 |
Why?
|
Peptide Fragments | 6 | 2022 | 702 | 0.310 |
Why?
|
Bacterial Proteins | 5 | 2022 | 759 | 0.310 |
Why?
|
Multiple Organ Failure | 3 | 2023 | 150 | 0.310 |
Why?
|
Glioblastoma | 2 | 2022 | 263 | 0.310 |
Why?
|
Purines | 3 | 2017 | 161 | 0.310 |
Why?
|
Mice, Inbred C57BL | 11 | 2021 | 4914 | 0.310 |
Why?
|
Signal Transduction | 14 | 2022 | 4713 | 0.300 |
Why?
|
Leukocyte Reduction Procedures | 2 | 2018 | 28 | 0.300 |
Why?
|
Asparagine | 2 | 2018 | 30 | 0.300 |
Why?
|
Sphingosine | 2 | 2017 | 35 | 0.300 |
Why?
|
Brain Injuries | 2 | 2022 | 484 | 0.290 |
Why?
|
Cell Proliferation | 10 | 2021 | 2275 | 0.290 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2017 | 42 | 0.290 |
Why?
|
STAT3 Transcription Factor | 2 | 2020 | 189 | 0.290 |
Why?
|
Receptor, Adenosine A2B | 2 | 2017 | 32 | 0.290 |
Why?
|
Proteoglycans | 3 | 2023 | 109 | 0.290 |
Why?
|
Fibrosis | 4 | 2023 | 483 | 0.290 |
Why?
|
Neoplasm Proteins | 3 | 2023 | 401 | 0.290 |
Why?
|
Lysophospholipids | 2 | 2017 | 68 | 0.290 |
Why?
|
Case-Control Studies | 9 | 2022 | 3173 | 0.290 |
Why?
|
Cryopreservation | 2 | 2017 | 99 | 0.280 |
Why?
|
Protein C | 2 | 2023 | 44 | 0.280 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2016 | 49 | 0.280 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2017 | 532 | 0.280 |
Why?
|
Neutrophil Activation | 2 | 2018 | 100 | 0.280 |
Why?
|
Transcriptome | 2 | 2022 | 756 | 0.280 |
Why?
|
Ribonucleoprotein, U5 Small Nuclear | 2 | 2017 | 12 | 0.270 |
Why?
|
Kynurenine | 3 | 2024 | 81 | 0.270 |
Why?
|
Drosophila Proteins | 3 | 2017 | 171 | 0.270 |
Why?
|
Reactive Oxygen Species | 7 | 2022 | 576 | 0.270 |
Why?
|
Prognosis | 8 | 2022 | 3443 | 0.270 |
Why?
|
Blood Component Transfusion | 3 | 2015 | 84 | 0.270 |
Why?
|
Fibrinolytic Agents | 3 | 2022 | 237 | 0.260 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2015 | 103 | 0.260 |
Why?
|
Obesity | 4 | 2020 | 2751 | 0.260 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 4 | 2012 | 171 | 0.260 |
Why?
|
Carbon Isotopes | 2 | 2017 | 115 | 0.260 |
Why?
|
In Vitro Techniques | 4 | 2021 | 1096 | 0.260 |
Why?
|
Lipid Metabolism | 4 | 2019 | 477 | 0.260 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2019 | 63 | 0.260 |
Why?
|
Cluster Analysis | 3 | 2016 | 481 | 0.260 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1794 | 0.260 |
Why?
|
Altitude | 4 | 2023 | 422 | 0.260 |
Why?
|
Thrombin | 3 | 2022 | 143 | 0.250 |
Why?
|
Integrins | 3 | 2023 | 82 | 0.250 |
Why?
|
Platelet Transfusion | 2 | 2023 | 68 | 0.250 |
Why?
|
Survival of Motor Neuron 1 Protein | 2 | 2016 | 7 | 0.250 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2009 | 146 | 0.250 |
Why?
|
Liver | 5 | 2018 | 1816 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2021 | 740 | 0.240 |
Why?
|
Cell Cycle Proteins | 5 | 2015 | 565 | 0.240 |
Why?
|
Glycosaminoglycans | 2 | 2022 | 78 | 0.240 |
Why?
|
Interferons | 2 | 2022 | 151 | 0.240 |
Why?
|
Blood Group Antigens | 1 | 2023 | 16 | 0.240 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2023 | 12 | 0.240 |
Why?
|
Bacteria | 2 | 2022 | 757 | 0.240 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 3 | 2022 | 240 | 0.240 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 2 | 2021 | 23 | 0.240 |
Why?
|
Repressor Proteins | 2 | 2018 | 377 | 0.240 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 336 | 0.240 |
Why?
|
Chromatography | 1 | 2003 | 25 | 0.230 |
Why?
|
Birth Injuries | 1 | 2023 | 11 | 0.230 |
Why?
|
Anemia, Sickle Cell | 2 | 2017 | 230 | 0.230 |
Why?
|
Trypsin | 1 | 2023 | 72 | 0.230 |
Why?
|
Fatty Acids | 3 | 2023 | 407 | 0.230 |
Why?
|
Hypocalcemia | 1 | 2023 | 31 | 0.230 |
Why?
|
Mammary Glands, Human | 2 | 2020 | 61 | 0.230 |
Why?
|
Phenotype | 7 | 2023 | 3004 | 0.230 |
Why?
|
Epithelial Cells | 5 | 2016 | 963 | 0.230 |
Why?
|
Chemical and Drug Induced Liver Injury, Chronic | 1 | 2023 | 9 | 0.230 |
Why?
|
Introns | 3 | 2019 | 234 | 0.230 |
Why?
|
Acclimatization | 4 | 2017 | 135 | 0.230 |
Why?
|
Neural Stem Cells | 2 | 2015 | 120 | 0.230 |
Why?
|
Acute-Phase Proteins | 2 | 2014 | 67 | 0.230 |
Why?
|
Betacoronavirus | 3 | 2020 | 254 | 0.220 |
Why?
|
Pelvic Organ Prolapse | 1 | 2023 | 41 | 0.220 |
Why?
|
Drosophila melanogaster | 3 | 2017 | 200 | 0.220 |
Why?
|
Isotonic Solutions | 4 | 2016 | 43 | 0.220 |
Why?
|
DNA-Binding Proteins | 4 | 2016 | 1346 | 0.220 |
Why?
|
Mitochondrial Proteins | 3 | 2016 | 226 | 0.220 |
Why?
|
Dystrophin | 1 | 2023 | 30 | 0.220 |
Why?
|
Collagen Type I | 1 | 2023 | 114 | 0.220 |
Why?
|
Serpins | 1 | 2022 | 26 | 0.220 |
Why?
|
Arginase | 1 | 2022 | 29 | 0.220 |
Why?
|
Membrane Transport Proteins | 2 | 2017 | 137 | 0.220 |
Why?
|
Proteolysis | 4 | 2020 | 146 | 0.220 |
Why?
|
Hemostasis | 1 | 2023 | 70 | 0.220 |
Why?
|
src-Family Kinases | 1 | 2023 | 90 | 0.220 |
Why?
|
Athletic Performance | 1 | 2023 | 46 | 0.220 |
Why?
|
Brain | 6 | 2021 | 2490 | 0.220 |
Why?
|
Gene Expression Regulation | 5 | 2022 | 2446 | 0.220 |
Why?
|
Ephrin-B2 | 2 | 2021 | 42 | 0.220 |
Why?
|
Erythroblasts | 1 | 2022 | 12 | 0.220 |
Why?
|
Citrulline | 1 | 2022 | 41 | 0.220 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2022 | 15 | 0.210 |
Why?
|
Complement C4 | 1 | 2022 | 26 | 0.210 |
Why?
|
Blood Transfusion | 5 | 2022 | 306 | 0.210 |
Why?
|
Transcription Factor TFIID | 1 | 2022 | 20 | 0.210 |
Why?
|
Cerebral Hemorrhage | 1 | 2023 | 100 | 0.210 |
Why?
|
Pulmonary Atelectasis | 1 | 2022 | 13 | 0.210 |
Why?
|
Thrombophilia | 1 | 2022 | 68 | 0.210 |
Why?
|
B7-H1 Antigen | 1 | 2023 | 144 | 0.210 |
Why?
|
beta-Globins | 1 | 2022 | 16 | 0.210 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 80 | 0.210 |
Why?
|
Isoaspartic Acid | 1 | 2021 | 3 | 0.210 |
Why?
|
Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.210 |
Why?
|
Oxygen | 5 | 2017 | 857 | 0.200 |
Why?
|
Blood | 1 | 2022 | 100 | 0.200 |
Why?
|
Coinfection | 1 | 2022 | 119 | 0.200 |
Why?
|
Pneumonia, Bacterial | 1 | 2022 | 110 | 0.200 |
Why?
|
Exons | 2 | 2019 | 308 | 0.200 |
Why?
|
Methods | 2 | 2018 | 67 | 0.200 |
Why?
|
Cathepsins | 1 | 2021 | 22 | 0.200 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2017 | 179 | 0.200 |
Why?
|
beta-Thalassemia | 1 | 2021 | 23 | 0.200 |
Why?
|
Mutation | 7 | 2021 | 3457 | 0.200 |
Why?
|
ADAM10 Protein | 1 | 2021 | 28 | 0.190 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2020 | 9 | 0.190 |
Why?
|
Virulence Factors | 1 | 2022 | 140 | 0.190 |
Why?
|
Glutathione | 3 | 2017 | 324 | 0.190 |
Why?
|
Seroconversion | 1 | 2021 | 48 | 0.190 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 26 | 0.190 |
Why?
|
Tenascin | 2 | 2018 | 13 | 0.190 |
Why?
|
Trans-Activators | 2 | 2020 | 373 | 0.190 |
Why?
|
RNA, Messenger | 4 | 2018 | 2661 | 0.190 |
Why?
|
Benzothiazoles | 2 | 2017 | 37 | 0.190 |
Why?
|
Oncogene Proteins | 1 | 2020 | 52 | 0.190 |
Why?
|
Least-Squares Analysis | 2 | 2021 | 73 | 0.190 |
Why?
|
Thrombomodulin | 1 | 2020 | 8 | 0.190 |
Why?
|
Cell Line | 9 | 2021 | 2707 | 0.190 |
Why?
|
Hematopoiesis | 2 | 2021 | 175 | 0.190 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2021 | 76 | 0.190 |
Why?
|
Genome | 1 | 2022 | 278 | 0.190 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2021 | 94 | 0.190 |
Why?
|
Oligonucleotides, Antisense | 1 | 2020 | 100 | 0.190 |
Why?
|
Glucosephosphate Dehydrogenase | 2 | 2019 | 41 | 0.190 |
Why?
|
Preoperative Period | 2 | 2019 | 110 | 0.190 |
Why?
|
Trauma Centers | 2 | 2020 | 388 | 0.190 |
Why?
|
Lysosomes | 1 | 2021 | 136 | 0.180 |
Why?
|
Acetaminophen | 1 | 2023 | 244 | 0.180 |
Why?
|
Nonprescription Drugs | 1 | 2021 | 67 | 0.180 |
Why?
|
Methionine | 2 | 2020 | 145 | 0.180 |
Why?
|
Glycosylation | 4 | 2015 | 129 | 0.180 |
Why?
|
RNA, Fungal | 2 | 2017 | 66 | 0.180 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 190 | 0.180 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 544 | 0.180 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2020 | 22 | 0.180 |
Why?
|
Pancreas | 2 | 2021 | 282 | 0.180 |
Why?
|
Fatty Acids, Nonesterified | 2 | 2020 | 167 | 0.180 |
Why?
|
Phenylurea Compounds | 2 | 2017 | 85 | 0.180 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 232 | 0.180 |
Why?
|
Spermatogenesis | 1 | 2020 | 53 | 0.180 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 183 | 0.180 |
Why?
|
Critical Illness | 2 | 2017 | 663 | 0.180 |
Why?
|
TCF Transcription Factors | 1 | 2019 | 21 | 0.180 |
Why?
|
Cardiomyopathies | 1 | 2023 | 299 | 0.180 |
Why?
|
Semaphorins | 1 | 2020 | 22 | 0.180 |
Why?
|
Databases, Genetic | 1 | 2021 | 253 | 0.180 |
Why?
|
Myeloid-Derived Suppressor Cells | 1 | 2020 | 57 | 0.180 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.180 |
Why?
|
Thyroid Neoplasms | 1 | 2023 | 278 | 0.180 |
Why?
|
Nucleotides | 2 | 2017 | 112 | 0.180 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2021 | 170 | 0.180 |
Why?
|
Acellular Dermis | 1 | 2019 | 13 | 0.180 |
Why?
|
Radiation Injuries | 1 | 2021 | 131 | 0.180 |
Why?
|
Pregnancy | 9 | 2023 | 5694 | 0.180 |
Why?
|
Parabiosis | 1 | 2019 | 12 | 0.180 |
Why?
|
Heart Failure | 2 | 2023 | 1968 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1390 | 0.180 |
Why?
|
Methyltransferases | 1 | 2020 | 61 | 0.180 |
Why?
|
Phosphorylation | 8 | 2018 | 1634 | 0.170 |
Why?
|
Chromatin | 3 | 2018 | 441 | 0.170 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 125 | 0.170 |
Why?
|
Neoplasm Invasiveness | 5 | 2020 | 462 | 0.170 |
Why?
|
2,3-Diphosphoglycerate | 4 | 2023 | 29 | 0.170 |
Why?
|
Semen Analysis | 2 | 2020 | 10 | 0.170 |
Why?
|
Prescription Drugs | 1 | 2021 | 113 | 0.170 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 314 | 0.170 |
Why?
|
Cell Survival | 5 | 2022 | 1047 | 0.170 |
Why?
|
Torpor | 1 | 2019 | 15 | 0.170 |
Why?
|
Mice, Knockout | 7 | 2021 | 2680 | 0.170 |
Why?
|
Fertility | 1 | 2020 | 135 | 0.170 |
Why?
|
Receptor, EphB4 | 1 | 2019 | 29 | 0.170 |
Why?
|
Thrombospondins | 1 | 2018 | 4 | 0.170 |
Why?
|
Herpes Zoster | 1 | 2023 | 336 | 0.170 |
Why?
|
Antifibrinolytic Agents | 2 | 2019 | 44 | 0.170 |
Why?
|
Chemical Fractionation | 2 | 2016 | 29 | 0.170 |
Why?
|
Stomach | 1 | 2019 | 103 | 0.170 |
Why?
|
Infertility, Male | 2 | 2020 | 61 | 0.170 |
Why?
|
Solubility | 2 | 2017 | 235 | 0.160 |
Why?
|
Aspartic Acid | 1 | 2018 | 86 | 0.160 |
Why?
|
Coenzymes | 1 | 2018 | 20 | 0.160 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 20 | 0.160 |
Why?
|
Diet, High-Fat | 1 | 2020 | 247 | 0.160 |
Why?
|
Erythrocyte Aging | 2 | 2016 | 6 | 0.160 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 23 | 0.160 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 471 | 0.160 |
Why?
|
Glioma | 1 | 2022 | 306 | 0.160 |
Why?
|
Mouse Embryonic Stem Cells | 1 | 2018 | 25 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2022 | 420 | 0.160 |
Why?
|
Renal Insufficiency | 1 | 2020 | 150 | 0.160 |
Why?
|
Adipose Tissue | 3 | 2020 | 606 | 0.160 |
Why?
|
Mechanotransduction, Cellular | 3 | 2023 | 101 | 0.160 |
Why?
|
Spermatozoa | 2 | 2020 | 91 | 0.160 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 1597 | 0.160 |
Why?
|
Arousal | 1 | 2019 | 157 | 0.160 |
Why?
|
Protein Conformation | 4 | 2021 | 848 | 0.160 |
Why?
|
Proteostasis | 1 | 2018 | 20 | 0.160 |
Why?
|
Arteries | 1 | 2020 | 250 | 0.160 |
Why?
|
Vascular Calcification | 1 | 2020 | 123 | 0.160 |
Why?
|
Laminin | 2 | 2021 | 68 | 0.160 |
Why?
|
Myocytes, Cardiac | 1 | 2022 | 472 | 0.160 |
Why?
|
Membrane Glycoproteins | 2 | 2011 | 446 | 0.160 |
Why?
|
Rats, Inbred F344 | 2 | 2016 | 245 | 0.160 |
Why?
|
Streptococcus pneumoniae | 1 | 2019 | 141 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 109 | 0.160 |
Why?
|
Ribonucleoprotein, U1 Small Nuclear | 1 | 2017 | 4 | 0.160 |
Why?
|
Hemoglobin, Sickle | 1 | 2017 | 16 | 0.160 |
Why?
|
Erythrocytes, Abnormal | 1 | 2017 | 16 | 0.160 |
Why?
|
Hemoglobin A | 1 | 2017 | 22 | 0.160 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2018 | 83 | 0.160 |
Why?
|
Aging | 3 | 2019 | 1677 | 0.160 |
Why?
|
Hypoxanthine | 1 | 2017 | 11 | 0.160 |
Why?
|
Benzeneacetamides | 1 | 2017 | 7 | 0.160 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 367 | 0.160 |
Why?
|
Glutaminase | 1 | 2017 | 9 | 0.160 |
Why?
|
Young Adult | 9 | 2021 | 10799 | 0.160 |
Why?
|
Cold Temperature | 2 | 2016 | 132 | 0.160 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2018 | 91 | 0.160 |
Why?
|
Multienzyme Complexes | 1 | 2017 | 64 | 0.150 |
Why?
|
Blotting, Western | 4 | 2020 | 1195 | 0.150 |
Why?
|
Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
|
Transcription, Genetic | 3 | 2019 | 1323 | 0.150 |
Why?
|
Histone Demethylases | 1 | 2017 | 28 | 0.150 |
Why?
|
Alternative Splicing | 2 | 2017 | 193 | 0.150 |
Why?
|
RNA Splicing Factors | 1 | 2017 | 50 | 0.150 |
Why?
|
Nanoparticles | 1 | 2021 | 325 | 0.150 |
Why?
|
Apoptosis | 5 | 2021 | 2484 | 0.150 |
Why?
|
DEAD-box RNA Helicases | 1 | 2017 | 56 | 0.150 |
Why?
|
Antigens, CD | 1 | 2020 | 460 | 0.150 |
Why?
|
Folic Acid Deficiency | 1 | 2017 | 48 | 0.150 |
Why?
|
Methylation | 5 | 2018 | 204 | 0.150 |
Why?
|
Fluid Therapy | 2 | 2016 | 131 | 0.150 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 12 | 0.150 |
Why?
|
Lung Diseases | 3 | 2018 | 718 | 0.150 |
Why?
|
Healthy Volunteers | 4 | 2021 | 201 | 0.150 |
Why?
|
Nitric Oxide | 1 | 2022 | 893 | 0.150 |
Why?
|
Blood Vessels | 1 | 2019 | 187 | 0.150 |
Why?
|
Autism Spectrum Disorder | 1 | 2022 | 324 | 0.150 |
Why?
|
Cystathionine | 1 | 2016 | 24 | 0.150 |
Why?
|
Organ Size | 2 | 2015 | 460 | 0.150 |
Why?
|
Periodicity | 1 | 2016 | 56 | 0.150 |
Why?
|
Molecular Chaperones | 2 | 2016 | 174 | 0.150 |
Why?
|
Basigin | 1 | 2017 | 27 | 0.150 |
Why?
|
Basement Membrane | 2 | 2016 | 32 | 0.150 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 59 | 0.150 |
Why?
|
Chromatography, Affinity | 1 | 2017 | 86 | 0.150 |
Why?
|
Binding Sites | 5 | 2021 | 1224 | 0.150 |
Why?
|
Mice, Inbred NOD | 4 | 2023 | 574 | 0.150 |
Why?
|
Influenza, Human | 1 | 2022 | 555 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 536 | 0.150 |
Why?
|
RNA, Small Nuclear | 2 | 2015 | 32 | 0.140 |
Why?
|
Leukemia | 1 | 2019 | 208 | 0.140 |
Why?
|
Mycophenolic Acid | 1 | 2017 | 79 | 0.140 |
Why?
|
Detergents | 1 | 2016 | 44 | 0.140 |
Why?
|
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 9 | 0.140 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 62 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 404 | 0.140 |
Why?
|
Bronchoalveolar Lavage Fluid | 5 | 2017 | 613 | 0.140 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2016 | 18 | 0.140 |
Why?
|
Hydrogen Sulfide | 1 | 2016 | 40 | 0.140 |
Why?
|
Integrin beta Chains | 1 | 2016 | 7 | 0.140 |
Why?
|
Folic Acid | 1 | 2017 | 161 | 0.140 |
Why?
|
Discriminant Analysis | 1 | 2016 | 41 | 0.140 |
Why?
|
Immunoglobulin E | 2 | 2009 | 366 | 0.140 |
Why?
|
Saline Solution, Hypertonic | 1 | 2016 | 56 | 0.140 |
Why?
|
Arachis | 2 | 2009 | 152 | 0.140 |
Why?
|
Glycoproteins | 2 | 2009 | 319 | 0.140 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2016 | 15 | 0.140 |
Why?
|
Mammals | 3 | 2022 | 253 | 0.140 |
Why?
|
Coiled Bodies | 1 | 2016 | 7 | 0.140 |
Why?
|
Alzheimer Disease | 1 | 2022 | 513 | 0.140 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2017 | 815 | 0.140 |
Why?
|
Orthomyxoviridae | 1 | 2016 | 37 | 0.140 |
Why?
|
RNA, Long Noncoding | 1 | 2018 | 161 | 0.140 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 709 | 0.140 |
Why?
|
Pilot Projects | 2 | 2018 | 1420 | 0.140 |
Why?
|
Body Temperature | 1 | 2016 | 215 | 0.140 |
Why?
|
Alcohol Oxidoreductases | 1 | 2016 | 57 | 0.140 |
Why?
|
Cellular Microenvironment | 1 | 2016 | 79 | 0.140 |
Why?
|
Nitrogen | 1 | 2017 | 154 | 0.140 |
Why?
|
Obesity, Morbid | 1 | 2019 | 197 | 0.140 |
Why?
|
Calcium | 5 | 2023 | 1171 | 0.140 |
Why?
|
Ubiquitination | 4 | 2018 | 87 | 0.140 |
Why?
|
Phosphatidylethanolamines | 1 | 2016 | 66 | 0.140 |
Why?
|
Transfusion Medicine | 1 | 2015 | 10 | 0.140 |
Why?
|
Orthomyxoviridae Infections | 1 | 2016 | 53 | 0.140 |
Why?
|
Macrophages | 2 | 2021 | 1324 | 0.140 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2016 | 83 | 0.140 |
Why?
|
Platelet Function Tests | 1 | 2015 | 25 | 0.140 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2016 | 193 | 0.140 |
Why?
|
Receptor, PAR-2 | 1 | 2015 | 8 | 0.140 |
Why?
|
Tryptophan Oxygenase | 1 | 2015 | 22 | 0.130 |
Why?
|
Cysteine | 1 | 2016 | 184 | 0.130 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2015 | 34 | 0.130 |
Why?
|
Reproducibility of Results | 4 | 2022 | 2874 | 0.130 |
Why?
|
Integrin beta3 | 1 | 2015 | 9 | 0.130 |
Why?
|
Anoikis | 1 | 2015 | 35 | 0.130 |
Why?
|
Bison | 1 | 2015 | 6 | 0.130 |
Why?
|
Oxygen Consumption | 2 | 2016 | 586 | 0.130 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2015 | 36 | 0.130 |
Why?
|
Phosphatidylcholines | 1 | 2016 | 133 | 0.130 |
Why?
|
Acute Lung Injury | 3 | 2016 | 310 | 0.130 |
Why?
|
Acidosis | 1 | 2016 | 86 | 0.130 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 360 | 0.130 |
Why?
|
Plasminogen | 1 | 2015 | 34 | 0.130 |
Why?
|
Breast | 3 | 2021 | 140 | 0.130 |
Why?
|
Blood Circulation | 1 | 2015 | 36 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2017 | 233 | 0.130 |
Why?
|
Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.130 |
Why?
|
Myocardial Infarction | 1 | 2022 | 968 | 0.130 |
Why?
|
RNA Helicases | 1 | 2015 | 20 | 0.130 |
Why?
|
Blood Volume | 1 | 2015 | 58 | 0.130 |
Why?
|
Mice, Nude | 4 | 2020 | 663 | 0.130 |
Why?
|
Serine Proteases | 1 | 2014 | 15 | 0.130 |
Why?
|
Kallikreins | 1 | 2014 | 33 | 0.130 |
Why?
|
Europe | 1 | 2015 | 356 | 0.130 |
Why?
|
Pulmonary Alveoli | 2 | 2008 | 384 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 985 | 0.130 |
Why?
|
Microcirculation | 1 | 2015 | 155 | 0.130 |
Why?
|
Thrombolytic Therapy | 1 | 2015 | 117 | 0.130 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 148 | 0.130 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2016 | 157 | 0.130 |
Why?
|
GTP-Binding Proteins | 2 | 2005 | 147 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2015 | 146 | 0.130 |
Why?
|
Allergens | 2 | 2009 | 425 | 0.120 |
Why?
|
Peanut Hypersensitivity | 2 | 2009 | 204 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 3 | 2022 | 176 | 0.120 |
Why?
|
Prospective Studies | 4 | 2022 | 6477 | 0.120 |
Why?
|
M Phase Cell Cycle Checkpoints | 1 | 2014 | 23 | 0.120 |
Why?
|
RNA Polymerase II | 2 | 2020 | 282 | 0.120 |
Why?
|
Seasons | 1 | 2016 | 462 | 0.120 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 551 | 0.120 |
Why?
|
Stroke | 1 | 2023 | 1046 | 0.120 |
Why?
|
Aurora Kinase A | 1 | 2014 | 52 | 0.120 |
Why?
|
Complex Mixtures | 1 | 2014 | 13 | 0.120 |
Why?
|
Skull | 1 | 2015 | 127 | 0.120 |
Why?
|
Tumor Cells, Cultured | 3 | 2021 | 874 | 0.120 |
Why?
|
Antigen Presentation | 1 | 2015 | 194 | 0.120 |
Why?
|
Myofibroblasts | 1 | 2015 | 120 | 0.120 |
Why?
|
Rejuvenation | 1 | 2013 | 14 | 0.120 |
Why?
|
Fetal Development | 1 | 2016 | 250 | 0.120 |
Why?
|
GPI-Linked Proteins | 3 | 2020 | 56 | 0.120 |
Why?
|
Microcephaly | 1 | 2014 | 54 | 0.120 |
Why?
|
Mitochondria | 2 | 2016 | 786 | 0.120 |
Why?
|
Dietary Supplements | 1 | 2017 | 467 | 0.120 |
Why?
|
Spindle Apparatus | 1 | 2014 | 86 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2017 | 469 | 0.120 |
Why?
|
Serine | 2 | 2023 | 138 | 0.120 |
Why?
|
Stem Cell Niche | 1 | 2013 | 43 | 0.120 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2013 | 29 | 0.120 |
Why?
|
Cryoelectron Microscopy | 3 | 2019 | 143 | 0.110 |
Why?
|
Estradiol | 2 | 2022 | 476 | 0.110 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 462 | 0.110 |
Why?
|
Cell Culture Techniques | 3 | 2013 | 356 | 0.110 |
Why?
|
Mitosis | 1 | 2014 | 172 | 0.110 |
Why?
|
Cell Adhesion | 3 | 2020 | 443 | 0.110 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2015 | 164 | 0.110 |
Why?
|
Biomarkers, Tumor | 1 | 2019 | 1059 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2019 | 2025 | 0.110 |
Why?
|
Cumulus Cells | 1 | 2012 | 6 | 0.110 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 628 | 0.110 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 188 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2019 | 812 | 0.110 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 683 | 0.110 |
Why?
|
Nuclear Proteins | 1 | 2017 | 597 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2012 | 38 | 0.110 |
Why?
|
Protein Interaction Maps | 1 | 2012 | 36 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2013 | 305 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 455 | 0.110 |
Why?
|
Protein Binding | 5 | 2018 | 1975 | 0.110 |
Why?
|
Liver Neoplasms | 1 | 2016 | 527 | 0.110 |
Why?
|
Growth Cones | 1 | 2012 | 6 | 0.110 |
Why?
|
Interleukin-1 | 1 | 2017 | 980 | 0.110 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 311 | 0.110 |
Why?
|
Catalytic Domain | 4 | 2018 | 206 | 0.110 |
Why?
|
Maternal Age | 1 | 2012 | 122 | 0.110 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 461 | 0.110 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 356 | 0.110 |
Why?
|
Precision Medicine | 1 | 2016 | 363 | 0.110 |
Why?
|
Stem Cells | 3 | 2022 | 559 | 0.110 |
Why?
|
Intestinal Mucosa | 1 | 2017 | 531 | 0.110 |
Why?
|
Follow-Up Studies | 2 | 2019 | 4596 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 671 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2022 | 1868 | 0.100 |
Why?
|
2S Albumins, Plant | 2 | 2009 | 29 | 0.100 |
Why?
|
Synaptotagmin I | 1 | 2011 | 13 | 0.100 |
Why?
|
HeLa Cells | 4 | 2018 | 583 | 0.100 |
Why?
|
Exoribonucleases | 1 | 2012 | 39 | 0.100 |
Why?
|
Antigens, Plant | 2 | 2009 | 53 | 0.100 |
Why?
|
Leukocytes | 1 | 2013 | 290 | 0.100 |
Why?
|
Protein Folding | 4 | 2018 | 250 | 0.100 |
Why?
|
Cell Movement | 4 | 2021 | 897 | 0.100 |
Why?
|
beta 2-Microglobulin | 1 | 2011 | 47 | 0.100 |
Why?
|
Aged | 8 | 2021 | 19661 | 0.100 |
Why?
|
Lipocalin 1 | 1 | 2011 | 2 | 0.100 |
Why?
|
Datasets as Topic | 2 | 2022 | 104 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2019 | 847 | 0.100 |
Why?
|
RNA Stability | 1 | 2012 | 97 | 0.100 |
Why?
|
Blastocyst | 1 | 2011 | 44 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2016 | 702 | 0.100 |
Why?
|
Transfusion Reaction | 1 | 2011 | 79 | 0.100 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 564 | 0.100 |
Why?
|
Culture Media | 1 | 2011 | 163 | 0.100 |
Why?
|
Lactates | 2 | 2023 | 87 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 1974 | 0.090 |
Why?
|
Aneuploidy | 1 | 2011 | 88 | 0.090 |
Why?
|
Exercise | 2 | 2023 | 1657 | 0.090 |
Why?
|
Axons | 1 | 2012 | 185 | 0.090 |
Why?
|
Water | 2 | 2022 | 425 | 0.090 |
Why?
|
DNA | 3 | 2022 | 1388 | 0.090 |
Why?
|
alpha 1-Antitrypsin | 1 | 2011 | 115 | 0.090 |
Why?
|
Isoantigens | 1 | 2009 | 19 | 0.090 |
Why?
|
RNA Precursors | 3 | 2017 | 136 | 0.090 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 11 | 0.090 |
Why?
|
Ischemia | 2 | 2023 | 374 | 0.090 |
Why?
|
BRCA1 Protein | 1 | 2010 | 57 | 0.090 |
Why?
|
Virulence | 2 | 2022 | 240 | 0.090 |
Why?
|
Fibrin Clot Lysis Time | 2 | 2019 | 8 | 0.090 |
Why?
|
HEK293 Cells | 3 | 2021 | 625 | 0.090 |
Why?
|
Prenatal Diagnosis | 1 | 2011 | 168 | 0.090 |
Why?
|
p300-CBP Transcription Factors | 1 | 2009 | 15 | 0.090 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 42 | 0.080 |
Why?
|
Cell Differentiation | 4 | 2020 | 1753 | 0.080 |
Why?
|
Bronchoscopes | 1 | 2008 | 5 | 0.080 |
Why?
|
Tryptophan | 2 | 2020 | 139 | 0.080 |
Why?
|
Complement Activation | 2 | 2022 | 350 | 0.080 |
Why?
|
Adolescent | 6 | 2021 | 18483 | 0.080 |
Why?
|
S100 Proteins | 1 | 2008 | 35 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 304 | 0.080 |
Why?
|
Neoplasms | 1 | 2022 | 2179 | 0.080 |
Why?
|
Tamoxifen | 1 | 2009 | 198 | 0.080 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 143 | 0.080 |
Why?
|
Models, Biological | 3 | 2021 | 1715 | 0.080 |
Why?
|
RNA Splice Sites | 2 | 2017 | 35 | 0.080 |
Why?
|
Computational Biology | 3 | 2012 | 588 | 0.080 |
Why?
|
Structure-Activity Relationship | 2 | 2019 | 522 | 0.080 |
Why?
|
Sulfur | 2 | 2019 | 44 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 4 | 2009 | 106 | 0.080 |
Why?
|
Protein Structure, Tertiary | 3 | 2020 | 823 | 0.080 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2007 | 9 | 0.080 |
Why?
|
Transcription Factors | 3 | 2018 | 1570 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 287 | 0.080 |
Why?
|
NADP | 2 | 2018 | 50 | 0.080 |
Why?
|
Sheep | 2 | 2021 | 764 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2016 | 1184 | 0.080 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 178 | 0.080 |
Why?
|
Interleukin-13 | 1 | 2008 | 135 | 0.080 |
Why?
|
Heart Ventricles | 2 | 2023 | 727 | 0.080 |
Why?
|
Protein Structure, Quaternary | 3 | 2019 | 116 | 0.070 |
Why?
|
Interleukin-4 | 1 | 2008 | 216 | 0.070 |
Why?
|
Neurons | 1 | 2015 | 1345 | 0.070 |
Why?
|
Catheterization, Peripheral | 1 | 2008 | 107 | 0.070 |
Why?
|
Th2 Cells | 1 | 2008 | 164 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 359 | 0.070 |
Why?
|
Plant Proteins | 1 | 2007 | 81 | 0.070 |
Why?
|
Sex Factors | 2 | 2023 | 1781 | 0.070 |
Why?
|
Biocompatible Materials | 2 | 2022 | 378 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2011 | 726 | 0.070 |
Why?
|
Ligands | 2 | 2019 | 567 | 0.070 |
Why?
|
5'-Nucleotidase | 2 | 2017 | 34 | 0.070 |
Why?
|
Cell Respiration | 2 | 2017 | 76 | 0.070 |
Why?
|
Keratinocytes | 1 | 2008 | 227 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2018 | 135 | 0.070 |
Why?
|
MicroRNAs | 3 | 2020 | 637 | 0.070 |
Why?
|
Protein Transport | 3 | 2016 | 412 | 0.070 |
Why?
|
Cohort Studies | 3 | 2023 | 5117 | 0.070 |
Why?
|
Respiratory Mucosa | 1 | 2008 | 254 | 0.070 |
Why?
|
Insulin | 1 | 2016 | 2170 | 0.070 |
Why?
|
Kupffer Cells | 1 | 2006 | 47 | 0.070 |
Why?
|
Oxidative Phosphorylation | 2 | 2017 | 156 | 0.070 |
Why?
|
Homeostasis | 2 | 2021 | 594 | 0.070 |
Why?
|
Adenosine Triphosphate | 2 | 2019 | 439 | 0.070 |
Why?
|
Cyclooxygenase 2 | 2 | 2020 | 168 | 0.070 |
Why?
|
Larva | 2 | 2017 | 213 | 0.070 |
Why?
|
Down-Regulation | 1 | 2008 | 627 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2018 | 508 | 0.070 |
Why?
|
Molecular Structure | 2 | 2004 | 459 | 0.070 |
Why?
|
Dithiothreitol | 1 | 2005 | 19 | 0.070 |
Why?
|
Threonine | 1 | 2005 | 45 | 0.060 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2004 | 5 | 0.060 |
Why?
|
Chromosome Segregation | 2 | 2015 | 35 | 0.060 |
Why?
|
Cystine | 2 | 2020 | 15 | 0.060 |
Why?
|
Fibronectins | 2 | 2020 | 114 | 0.060 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2016 | 196 | 0.060 |
Why?
|
Fanconi Syndrome | 1 | 2004 | 2 | 0.060 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2016 | 333 | 0.060 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2004 | 50 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 811 | 0.060 |
Why?
|
Microscopy, Atomic Force | 2 | 2016 | 118 | 0.060 |
Why?
|
Survival Rate | 2 | 2021 | 1720 | 0.060 |
Why?
|
Dermatitis, Atopic | 1 | 2008 | 332 | 0.060 |
Why?
|
RNA Interference | 2 | 2017 | 460 | 0.060 |
Why?
|
Ion Channels | 1 | 2004 | 126 | 0.060 |
Why?
|
Urine | 1 | 2004 | 59 | 0.060 |
Why?
|
Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 16 | 0.060 |
Why?
|
Surface-Active Agents | 1 | 2004 | 81 | 0.060 |
Why?
|
Hemodynamics | 2 | 2021 | 1004 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2019 | 1085 | 0.060 |
Why?
|
Linear Models | 2 | 2017 | 827 | 0.060 |
Why?
|
Snake Venoms | 1 | 2023 | 17 | 0.060 |
Why?
|
Succinates | 1 | 2023 | 18 | 0.060 |
Why?
|
Pelvic Floor | 1 | 2023 | 24 | 0.060 |
Why?
|
Nucleocapsid Proteins | 1 | 2023 | 24 | 0.060 |
Why?
|
Nucleocapsid | 1 | 2023 | 17 | 0.060 |
Why?
|
NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 19 | 0.060 |
Why?
|
Genome, Human | 2 | 2022 | 386 | 0.060 |
Why?
|
Kidney Tubules, Proximal | 1 | 2004 | 131 | 0.060 |
Why?
|
Factor XIII | 1 | 2023 | 8 | 0.060 |
Why?
|
Mice, Inbred mdx | 1 | 2023 | 11 | 0.060 |
Why?
|
Factor V | 1 | 2023 | 23 | 0.060 |
Why?
|
Dasatinib | 1 | 2023 | 46 | 0.060 |
Why?
|
Phospholipases A2 | 1 | 2023 | 77 | 0.060 |
Why?
|
Cyclophilins | 1 | 2023 | 29 | 0.060 |
Why?
|
Cytotoxins | 1 | 2022 | 16 | 0.060 |
Why?
|
Parturition | 1 | 2023 | 53 | 0.060 |
Why?
|
Reperfusion | 1 | 2023 | 43 | 0.060 |
Why?
|
Blood Coagulation Tests | 1 | 2023 | 58 | 0.060 |
Why?
|
Heparitin Sulfate | 1 | 2022 | 42 | 0.060 |
Why?
|
Metalloproteases | 1 | 2023 | 38 | 0.060 |
Why?
|
Iodine Radioisotopes | 1 | 2023 | 130 | 0.060 |
Why?
|
Thymidine | 1 | 2022 | 62 | 0.050 |
Why?
|
Models, Genetic | 2 | 2018 | 595 | 0.050 |
Why?
|
P-Selectin | 1 | 2022 | 26 | 0.050 |
Why?
|
Mexico | 1 | 2023 | 165 | 0.050 |
Why?
|
Glutamic Acid | 2 | 2017 | 224 | 0.050 |
Why?
|
Erythropoiesis | 1 | 2022 | 33 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2022 | 26 | 0.050 |
Why?
|
Immunoprecipitation | 2 | 2015 | 161 | 0.050 |
Why?
|
Random Allocation | 1 | 2023 | 349 | 0.050 |
Why?
|
CD36 Antigens | 1 | 2022 | 42 | 0.050 |
Why?
|
Bicycling | 1 | 2023 | 77 | 0.050 |
Why?
|
Cardiomegaly | 1 | 2023 | 168 | 0.050 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2023 | 146 | 0.050 |
Why?
|
alpha-Globins | 1 | 2022 | 12 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2022 | 70 | 0.050 |
Why?
|
United States | 2 | 2015 | 12557 | 0.050 |
Why?
|
Platelet Activation | 1 | 2022 | 70 | 0.050 |
Why?
|
Exosomes | 1 | 2023 | 92 | 0.050 |
Why?
|
Arachidonic Acid | 1 | 2022 | 122 | 0.050 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2022 | 55 | 0.050 |
Why?
|
Platelet Aggregation | 1 | 2022 | 97 | 0.050 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2023 | 197 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2023 | 181 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 1323 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2022 | 220 | 0.050 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 197 | 0.050 |
Why?
|
Ranitidine | 1 | 2021 | 13 | 0.050 |
Why?
|
Membrane Microdomains | 1 | 2021 | 35 | 0.050 |
Why?
|
Hypoalbuminemia | 1 | 2021 | 27 | 0.050 |
Why?
|
Immune Evasion | 1 | 2021 | 48 | 0.050 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2020 | 7 | 0.050 |
Why?
|
Trastuzumab | 1 | 2021 | 92 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 204 | 0.050 |
Why?
|
Alveolar Epithelial Cells | 1 | 2022 | 102 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 2 | 2013 | 410 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2023 | 229 | 0.050 |
Why?
|
Access to Information | 1 | 2021 | 53 | 0.050 |
Why?
|
Rats, Wistar | 1 | 2022 | 399 | 0.050 |
Why?
|
Disease Progression | 2 | 2020 | 2490 | 0.050 |
Why?
|
Ventricular Function, Right | 1 | 2023 | 257 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 146 | 0.050 |
Why?
|
Bacteriophage lambda | 1 | 2021 | 81 | 0.050 |
Why?
|
Lactation | 1 | 2021 | 160 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 77 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 1167 | 0.050 |
Why?
|
Up-Regulation | 2 | 2016 | 872 | 0.050 |
Why?
|
Cell Count | 2 | 2013 | 315 | 0.050 |
Why?
|
Sulfhydryl Compounds | 1 | 2022 | 179 | 0.050 |
Why?
|
Aorta | 1 | 2023 | 367 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2023 | 642 | 0.050 |
Why?
|
Gene Expression | 2 | 2019 | 1492 | 0.050 |
Why?
|
Polyamines | 1 | 2020 | 39 | 0.050 |
Why?
|
Mice, Obese | 1 | 2020 | 58 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2017 | 1308 | 0.050 |
Why?
|
Creatine | 1 | 2020 | 56 | 0.050 |
Why?
|
Data Mining | 1 | 2021 | 113 | 0.050 |
Why?
|
Sperm Count | 1 | 2020 | 16 | 0.050 |
Why?
|
Heterozygote | 1 | 2021 | 262 | 0.050 |
Why?
|
Calcification, Physiologic | 1 | 2020 | 34 | 0.050 |
Why?
|
Rabbits | 2 | 2014 | 780 | 0.050 |
Why?
|
Sperm Motility | 1 | 2020 | 28 | 0.050 |
Why?
|
Cattle | 1 | 2023 | 979 | 0.050 |
Why?
|
CD146 Antigen | 1 | 2020 | 41 | 0.050 |
Why?
|
Astrocytes | 1 | 2021 | 177 | 0.050 |
Why?
|
Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 23 | 0.050 |
Why?
|
MCF-7 Cells | 1 | 2020 | 111 | 0.040 |
Why?
|
Specimen Handling | 1 | 2021 | 165 | 0.040 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2019 | 45 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 105 | 0.040 |
Why?
|
Genotype | 2 | 2016 | 1882 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2019 | 205 | 0.040 |
Why?
|
Chromatography, Gel | 2 | 2009 | 133 | 0.040 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 200 | 0.040 |
Why?
|
Phylogeny | 1 | 2023 | 817 | 0.040 |
Why?
|
Cell Cycle | 2 | 2014 | 550 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 355 | 0.040 |
Why?
|
Tissue Survival | 1 | 2018 | 13 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 189 | 0.040 |
Why?
|
Anticoagulants | 1 | 2023 | 559 | 0.040 |
Why?
|
Bacterial Adhesion | 1 | 2019 | 79 | 0.040 |
Why?
|
Herpesvirus 3, Human | 1 | 2023 | 389 | 0.040 |
Why?
|
Blood Glucose | 2 | 2020 | 1946 | 0.040 |
Why?
|
Cell Communication | 1 | 2020 | 281 | 0.040 |
Why?
|
Receptor, ErbB-2 | 1 | 2021 | 320 | 0.040 |
Why?
|
Pepsin A | 1 | 2018 | 18 | 0.040 |
Why?
|
Surface Tension | 1 | 2018 | 9 | 0.040 |
Why?
|
Blood Buffy Coat | 1 | 2018 | 6 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2021 | 334 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 127 | 0.040 |
Why?
|
Drug Design | 1 | 2019 | 160 | 0.040 |
Why?
|
Sulfates | 1 | 2018 | 47 | 0.040 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2023 | 635 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2019 | 222 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2011 | 336 | 0.040 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2018 | 69 | 0.040 |
Why?
|
Creatinine | 1 | 2020 | 491 | 0.040 |
Why?
|
Feedback, Physiological | 1 | 2018 | 75 | 0.040 |
Why?
|
Inpatients | 1 | 2022 | 389 | 0.040 |
Why?
|
Acute Disease | 2 | 2013 | 941 | 0.040 |
Why?
|
Filtration | 1 | 2018 | 64 | 0.040 |
Why?
|
Fluorescence | 1 | 2018 | 159 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 66 | 0.040 |
Why?
|
Cartilage | 1 | 2019 | 184 | 0.040 |
Why?
|
Deamination | 1 | 2017 | 5 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2022 | 545 | 0.040 |
Why?
|
Radiotherapy | 1 | 2019 | 187 | 0.040 |
Why?
|
Nitrogen Isotopes | 1 | 2017 | 55 | 0.040 |
Why?
|
Crush Injuries | 1 | 2017 | 10 | 0.040 |
Why?
|
Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.040 |
Why?
|
Paclitaxel | 1 | 2019 | 195 | 0.040 |
Why?
|
Base Pairing | 1 | 2017 | 59 | 0.040 |
Why?
|
Biocatalysis | 1 | 2017 | 64 | 0.040 |
Why?
|
Freezing | 1 | 2017 | 87 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2017 | 71 | 0.040 |
Why?
|
Metabolism | 1 | 2017 | 39 | 0.040 |
Why?
|
Rats, Zucker | 2 | 2008 | 34 | 0.040 |
Why?
|
Doxorubicin | 1 | 2019 | 302 | 0.040 |
Why?
|
Mast Cells | 2 | 2009 | 115 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2017 | 33 | 0.040 |
Why?
|
Base Sequence | 2 | 2013 | 2160 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 398 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 842 | 0.040 |
Why?
|
Machine Learning | 1 | 2021 | 331 | 0.040 |
Why?
|
Quorum Sensing | 1 | 2018 | 72 | 0.040 |
Why?
|
Reference Standards | 1 | 2017 | 176 | 0.040 |
Why?
|
Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
|
Limit of Detection | 1 | 2017 | 55 | 0.040 |
Why?
|
Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2017 | 22 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2021 | 454 | 0.040 |
Why?
|
Primates | 1 | 2018 | 114 | 0.040 |
Why?
|
Femoral Fractures | 1 | 2017 | 67 | 0.040 |
Why?
|
Body Fluids | 1 | 2017 | 62 | 0.040 |
Why?
|
Freeze Drying | 1 | 2017 | 75 | 0.040 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2019 | 156 | 0.040 |
Why?
|
Weaning | 1 | 2016 | 57 | 0.040 |
Why?
|
Biopsy | 1 | 2020 | 1079 | 0.040 |
Why?
|
Bisphosphoglycerate Mutase | 1 | 2016 | 6 | 0.040 |
Why?
|
Macaca | 1 | 2016 | 54 | 0.040 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 5 | 0.040 |
Why?
|
Hydrazines | 1 | 2016 | 31 | 0.040 |
Why?
|
Bronchioles | 1 | 2016 | 23 | 0.040 |
Why?
|
Databases, Protein | 1 | 2016 | 60 | 0.040 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 464 | 0.040 |
Why?
|
ErbB Receptors | 1 | 2020 | 569 | 0.040 |
Why?
|
Deoxyglucose | 1 | 2016 | 46 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2019 | 166 | 0.040 |
Why?
|
Fetal Hemoglobin | 1 | 2016 | 8 | 0.040 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 99 | 0.040 |
Why?
|
Myoblasts | 1 | 2017 | 75 | 0.040 |
Why?
|
Sesquiterpenes | 1 | 2016 | 51 | 0.040 |
Why?
|
Adventitia | 1 | 2016 | 39 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2016 | 87 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 62 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2020 | 1687 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2016 | 37 | 0.030 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 140 | 0.030 |
Why?
|
Comorbidity | 1 | 2021 | 1527 | 0.030 |
Why?
|
Military Personnel | 2 | 2014 | 529 | 0.030 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2016 | 18 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 280 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 1206 | 0.030 |
Why?
|
Blood Viscosity | 1 | 2015 | 19 | 0.030 |
Why?
|
Receptors, Interleukin-1 | 1 | 2017 | 228 | 0.030 |
Why?
|
Chromatids | 1 | 2015 | 8 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 275 | 0.030 |
Why?
|
Kidney | 1 | 2023 | 1357 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2018 | 305 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2016 | 180 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 290 | 0.030 |
Why?
|
Biochemistry | 1 | 2015 | 40 | 0.030 |
Why?
|
HMGA2 Protein | 1 | 2015 | 8 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2015 | 88 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2015 | 138 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2015 | 76 | 0.030 |
Why?
|
Sirolimus | 1 | 2016 | 195 | 0.030 |
Why?
|
Chromosomes | 1 | 2015 | 87 | 0.030 |
Why?
|
Electroporation | 1 | 2015 | 33 | 0.030 |
Why?
|
Genes, Fungal | 1 | 2015 | 49 | 0.030 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2016 | 192 | 0.030 |
Why?
|
Biomechanical Phenomena | 1 | 2018 | 683 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 237 | 0.030 |
Why?
|
Reproduction | 1 | 2016 | 189 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2017 | 219 | 0.030 |
Why?
|
Genetic Markers | 1 | 2016 | 348 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2021 | 1063 | 0.030 |
Why?
|
Elasticity | 1 | 2015 | 193 | 0.030 |
Why?
|
Body Size | 1 | 2015 | 94 | 0.030 |
Why?
|
Thoracotomy | 1 | 2015 | 84 | 0.030 |
Why?
|
Physical Conditioning, Animal | 1 | 2017 | 204 | 0.030 |
Why?
|
Mice, SCID | 1 | 2015 | 333 | 0.030 |
Why?
|
Erythrocyte Indices | 1 | 2014 | 29 | 0.030 |
Why?
|
Seminal Plasma Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 175 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 368 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2019 | 1691 | 0.030 |
Why?
|
Transfection | 1 | 2017 | 890 | 0.030 |
Why?
|
Embryo Implantation | 1 | 2014 | 24 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2018 | 316 | 0.030 |
Why?
|
Chromosomal Instability | 1 | 2014 | 18 | 0.030 |
Why?
|
Cations | 1 | 2014 | 79 | 0.030 |
Why?
|
Running | 1 | 2017 | 227 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2016 | 828 | 0.030 |
Why?
|
Intestines | 1 | 2017 | 332 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2018 | 556 | 0.030 |
Why?
|
Exercise Test | 1 | 2017 | 551 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2016 | 313 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2014 | 156 | 0.030 |
Why?
|
Fetal Stem Cells | 1 | 2013 | 7 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2014 | 73 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2008 | 749 | 0.030 |
Why?
|
DNA Repair | 1 | 2015 | 198 | 0.030 |
Why?
|
Regression Analysis | 1 | 2016 | 984 | 0.030 |
Why?
|
Risk Assessment | 1 | 2023 | 3057 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 965 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 114 | 0.030 |
Why?
|
Embryonic Development | 1 | 2014 | 119 | 0.030 |
Why?
|
Synovial Membrane | 1 | 2013 | 72 | 0.030 |
Why?
|
Biological Transport | 1 | 2014 | 382 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 870 | 0.030 |
Why?
|
Enzymes | 1 | 2013 | 66 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 539 | 0.030 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2013 | 23 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 1267 | 0.030 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2012 | 3 | 0.030 |
Why?
|
Oocyte Donation | 1 | 2012 | 5 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 410 | 0.030 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2012 | 15 | 0.030 |
Why?
|
Athletes | 1 | 2016 | 353 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2016 | 737 | 0.030 |
Why?
|
Fetus | 1 | 2016 | 690 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 1067 | 0.030 |
Why?
|
Protein Stability | 1 | 2012 | 164 | 0.030 |
Why?
|
Body Mass Index | 1 | 2020 | 2092 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 2015 | 285 | 0.030 |
Why?
|
Cadherins | 1 | 2013 | 186 | 0.030 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 150 | 0.030 |
Why?
|
Hospitalization | 1 | 2021 | 1785 | 0.030 |
Why?
|
Carbohydrates | 1 | 2012 | 59 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2015 | 1474 | 0.030 |
Why?
|
Patient Selection | 1 | 2015 | 675 | 0.030 |
Why?
|
Cell Membrane | 1 | 2015 | 710 | 0.030 |
Why?
|
Temperature | 1 | 2014 | 622 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2012 | 104 | 0.030 |
Why?
|
NF-kappa B | 1 | 2015 | 670 | 0.030 |
Why?
|
Insecta | 1 | 2011 | 68 | 0.020 |
Why?
|
Embryo Culture Techniques | 1 | 2011 | 10 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 158 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2014 | 238 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2015 | 9346 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2011 | 338 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2011 | 546 | 0.020 |
Why?
|
Carcinogens | 1 | 2011 | 108 | 0.020 |
Why?
|
Polyubiquitin | 1 | 2009 | 7 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 412 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2019 | 12990 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 59 | 0.020 |
Why?
|
Antioxidants | 1 | 2013 | 564 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2009 | 139 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2009 | 100 | 0.020 |
Why?
|
Retinoblastoma-Binding Protein 4 | 1 | 2009 | 4 | 0.020 |
Why?
|
Sirtuin 2 | 1 | 2009 | 13 | 0.020 |
Why?
|
Sirtuin 1 | 1 | 2009 | 30 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 173 | 0.020 |
Why?
|
Sirtuins | 1 | 2009 | 34 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 276 | 0.020 |
Why?
|
Molecular Weight | 1 | 2009 | 343 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 381 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 307 | 0.020 |
Why?
|
Cytokines | 1 | 2016 | 1900 | 0.020 |
Why?
|
beta-Defensins | 1 | 2008 | 22 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 217 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2008 | 69 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2016 | 2674 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 343 | 0.020 |
Why?
|
Yersinia enterocolitica | 1 | 2007 | 6 | 0.020 |
Why?
|
Colorado | 1 | 2017 | 4196 | 0.020 |
Why?
|
Basophil Degranulation Test | 1 | 2007 | 7 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 982 | 0.020 |
Why?
|
Hippocampus | 1 | 2012 | 735 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2009 | 198 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 1244 | 0.020 |
Why?
|
Estrogens | 1 | 2010 | 329 | 0.020 |
Why?
|
Basophils | 1 | 2007 | 66 | 0.020 |
Why?
|
Risk Factors | 1 | 2020 | 9003 | 0.020 |
Why?
|
Tidal Volume | 1 | 2007 | 74 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2014 | 589 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 775 | 0.020 |
Why?
|
Pulmonary Ventilation | 1 | 2007 | 71 | 0.020 |
Why?
|
DNA Damage | 1 | 2009 | 357 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2007 | 129 | 0.020 |
Why?
|
Calgranulin B | 1 | 2006 | 6 | 0.020 |
Why?
|
Child | 2 | 2021 | 19137 | 0.020 |
Why?
|
Peroxidases | 1 | 2006 | 29 | 0.020 |
Why?
|
Peroxiredoxins | 1 | 2006 | 23 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2006 | 97 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 336 | 0.020 |
Why?
|
Autoanalysis | 1 | 2005 | 6 | 0.020 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2006 | 74 | 0.020 |
Why?
|
Peroxidase | 1 | 2006 | 170 | 0.020 |
Why?
|
Plant Extracts | 1 | 2007 | 165 | 0.020 |
Why?
|
Point Mutation | 1 | 2006 | 228 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 364 | 0.020 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2005 | 15 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2006 | 134 | 0.020 |
Why?
|
Shal Potassium Channels | 1 | 2004 | 6 | 0.020 |
Why?
|
Calibration | 1 | 2005 | 135 | 0.020 |
Why?
|
Complement C3 | 1 | 2006 | 192 | 0.020 |
Why?
|
Deuterium | 1 | 2005 | 78 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2006 | 422 | 0.020 |
Why?
|
Hydrolysis | 1 | 2005 | 176 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2005 | 119 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3361 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2006 | 217 | 0.020 |
Why?
|
Static Electricity | 1 | 2004 | 121 | 0.020 |
Why?
|
Cytosol | 1 | 2005 | 221 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2004 | 413 | 0.020 |
Why?
|
Models, Animal | 1 | 2006 | 363 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 339 | 0.010 |
Why?
|
Isoenzymes | 1 | 2004 | 297 | 0.010 |
Why?
|
Protein Subunits | 1 | 2004 | 211 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 1947 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 2179 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 1637 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 2062 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2004 | 266 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 9493 | 0.010 |
Why?
|